Navigation Links
Improvement needed for mastectomy outcome reporting
Date:12/3/2010

Improved standards for outcome reporting in breast reconstruction are needed, according to a review published online December 3rd in The Journal of the National Cancer Institute.

Every year in the United States up to 40% of women with breast cancer undergo a mastectomy. They say the most valuable factor in their decision-making is information from health professionals. However, that information is largely dependent on the quality, reporting, and interpretation of research data on surgical procedures.

To summarize the reporting standards of surgical outcomes in breast reconstruction, Shelley Potter, M.D., of the University of Bristol, and colleagues, reviewed 134 studies reporting surgical outcomes of breast reconstruction involving over 42,000 women. Over half of the studies, or 55%, were cohort studies, 36.6% were case series studies, and 8.2% were randomized controlled trials. Specifically, the researchers looked at prospective or retrospective accrual of data, duration of follow-up, proportion of complications, reporting of total and procedure-specific complications, severity of complications, length of hospital stay and adjustment for risk factors such as smoking or radiotherapy.

The researchers found an overall dearth of reporting and inconsistency in the data regarding outcomes of breast reconstruction. The studies defined clearly fewer than 20% of the complications they reported, and only half the studies considered risk factors for adverse outcomes. The authors write, "Details such as the severity of complications (41.8% of all studies), duration of follow-up (58.2%) and overall complication rates (59.7%) were often omitted." Furthermore, many studies had important methodological problems.

The authors write that their review has indicated the need for a standardized approach to outcome assessment in breast reconstruction that also includes non-clinical factors. They write, "Traditional clinical outcomes rem
'/>"/>

Contact: Kristine Crane
jncimedia@oxfordjournals.org
301-841-1285
Journal of the National Cancer Institute
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. CustomerCentric Selling and Kadient Announce Joint Event in Boston to Launch Strategic Partnership for Sales Enablement and Improvement
2. Medical Imaging Northwest Completes Phase I of Its Healthcare IT Integration to Maintain Patient Care Improvements
3. Innovation Initiative Underway for Health Records Improvements
4. Improvement Now Made Easier With Self-Improvement-Life-Coach.com
5. Visual Cues that Improve Walking for People with Movement Disorders - Study Shows Small Change in Arrangement Can Make a Big Difference in Improvement Gained
6. Improvements needed in genomic test result discussions
7. Parrish Medical Center Sees 30 Percent Improvement in Mortality Using Real-Time Clinical Surveillance Solution from Thomson Reuters
8. Fatal Arizona Bus Accident Points Out Need for Improvements in Charter Bus Safety
9. Lifesaving Bills Filed in Florida Legislature to Guarantee Patient Safety Improvements
10. Long Island Children's Orthodontist Announces Office Improvements And New Staff Member
11. Cosmetic and Plastic Surgery Web Site Announces Improvements to the Patient Process of Finding Cosmetic Doctors in Their Area
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... CCA , America's leader in partnership ... Vice President, Health Services, effective June 8, 2013. ... for CCA. He will replace the retiring Herb ... to lead CCA's dedicated team of health care professionals. ... and our partners as we provide effective care to ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Strict ... In July 2013, Orriant is launching a new ... and maintain compliance with regulations. New HHS ... receive wellness incentives if their employer offers outcome-based, ... have been compliant with these standards for nearly ...
(Date:6/19/2013)... Citi Bike has come to New York City ... Perna to know for sure how many patients will choose to ... have the option. In fact, he’s happy about anything that ... make it more convenient for them to visit his office at ... Complimentary Alternative Medicine at Back and Body Medical and an experienced ...
(Date:6/19/2013)... surgery have had a significant impact on survival ... injuries, including burns. Patients who survive the ... greatest risk from infections particularly the overwhelming, ... from inflammation-induced multiorgan failure. Now, a device ... measures the movement of key immune cells may ...
(Date:6/19/2013)... (June 19, 2013) The results of three important ... Neurosurgery , official journal of the Congress ... by Lippincott Williams & Wilkins , a part ... indicates that continuous "machine learning" using artificial neural networks ... patients with advanced brain cancers. Another study in the ...
Breaking Medicine News(10 mins):Health News:CCA Names Dr. John Baxter Vice President, Health Services 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 3Health News:Restoring appropriate movement to immune cells may save seriously burned patients 2Health News:Restoring appropriate movement to immune cells may save seriously burned patients 3Health News:Neurosurgery publishes findings of 3 important studies in June issue 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 3
... leukemia, also shows promise against a type of stomach cancer ... a promising anti-leukemia drug for treatment of a relatively rare ... pill once a day, is effective in treating both forms ... cancer cells without attacking healthy cells and causing severe side ...
... mothers can modify the length of other women's menstrual ... mother - or their infants - made the cycles ... Ohio University.// ,She suggests this is due to ... as part of a human's desire to raise children ...
... Hopkins University School of Medicine have recently found that the ... that lets us stop smelling something, even though the odour ... issue of the journal Science show that a protein called ... job of these reurons is to detect smells and send ...
... immune cells which help protect us from disease does not ... it could be something to do with their shape. ... how immune cells behave in microgravity as part of their ... ,It has been found that astronauts have elevated virus levels ...
... The Federal Drug Administration approved OxyContin in late 1995 ... early 1996. Between that time and 2000, prescriptions for ... that they could get a powerful heroin-like high by ... powder.// ,Abuse of OxyContin, the nation's best ...
... Kava is derived from a leafy plant native to the ... implicated in approximately 25 cases of liver diseases. The herb ... to treat insomnia, anxiety, stress and muscle spasms. According to ... as// benzodiazepines but is not chemically related. ,Benzodiazepines have ...
Cached Medicine News:Health News:Immune cells halt round in space 2
(Date:6/19/2013)... Pharmacyclics, Inc. (the "Company") (Nasdaq: ... Journal of Medicine ( NEJM ) published results ... Bruton,s tyrosine kinase (BTK) inhibitor ibrutinib in patients with ... ibrutinib may be effective and generally well-tolerated in patients ... separate study examining the safety and efficacy of ibrutinib ...
(Date:6/19/2013)... BRAINTREE, Mass. , June 19, 2013 /PRNewswire/ ... announced several important developments in the pursuit of ... (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) , ... SANM ) for the future production of medical ... , Massachusetts. Sanmina is a leading global provider of ...
(Date:6/19/2013)... 2013 /PRNewswire-iReach/ -- Robert M. Bernstein, M.D., ... procedures and founder of Bernstein Medical – Center ... Doctors, issue of New York Magazine for the ... ) Dr. Bernstein earned his ... reputation as world-renowned hair restoration physician, through a ...
Breaking Medicine Technology:Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 2Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 3Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 4Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 5Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 6Haemonetics Announces Next Steps in Manufacturing Transformation 2Haemonetics Announces Next Steps in Manufacturing Transformation 3Haemonetics Announces Next Steps in Manufacturing Transformation 4Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 2Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 3
... 27 Kinex Pharmaceuticals will present results from a Phase ... Meeting in Orlando, on May 29, 2009. The study ... (RPCI) and Fox Chase Cancer Center. Dr. Alex Adjei, ... "Results of a phase I trial of KX2-391, a novel ...
... Administered in Dual Cord Blood Transplant for Hematologic MalignancyLA JOLLA, ... announced today that the first patient has been treated ... molecule Stem Cell Modulator (SCM) designed to increase hematopoietic stem ... pathways that guide cell fate. The study, which is ...
Cached Medicine Technology:Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support 2Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support 3Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support 4
Intended for the quantitative determination of magnesium in serum or plasma. Reaction: Endpoint. Wavelength: 520 nm. Linearity: 6.0 mg/dL (2.5 mmol/L)....
For the quantitative determination of Magnesium in serum. Linearity: 4.0 mEq/L. Working Reagent prepared by simple 1:10 dilution....
For the quantitative determination of total glucose in serum....
Glucose reagent is used for the quantitative determination of glucose in human serum....
Medicine Products: